Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?-Reference-Cited by-同舟云学术

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?

Published:2020-10-28 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Monti Paola,Menichini Paola,Speciale Andrea,Cutrona Giovanna,Fais Franco,Taiana Elisa,Neri Antonino,Bomben Riccardo,Gentile Massimo,Gattei Valter,Ferrarini Manlio,Morabito Fortunato,Fronza Gilberto

Funder

Compagnia di San Paolo

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference90 articles.

1. Crawford LV. T antigen is bound to a host protein in SV40-transformed cells;Lane;Nature,1979

2. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells;Linzer;Cell,1979

3. Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum;Kress;J Virol,1979

4. The p53 proto-oncogene can act as a suppressor of transformation;Finlay;Cell,1989

5. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas;Baker;Science,1989

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Imaging of p53 in Mouse Models of Cancer Using a Radiolabeled Antibody TAT Conjugate with SPECT;Journal of Nuclear Medicine;2024-09-12

2. Assessment of the Circulating PD-1 and PD-L1 Levels and P53 Expression as a Predictor of Relapse in Pediatric Patients with Wilms Tumor and Hypernephroma;Children;2024-08-23

3. TP53 mutations in myeloid neoplasms: implications for accurate laboratory detection, diagnosis, and treatment;Laboratory Medicine;2024-07-13

4. Pathogenic variants in human DNA damage repair genes mostly arose after the latest human out-of-Africa migration;Frontiers in Genetics;2024-06-14

5. The clinical features and prognostic implications of the co-mutated TP53 gene in advanced non-small cell lung cancer;Clinical and Translational Oncology;2024-06-13